HEALTHCARE COSTS OF IPILIMUMAB IN PATIENTS WITH ADVANCED CUTANEOUS MELANOMA IN DUTCH CLINICAL PRACTICE
Author(s):
Franken, M.; Leeneman, B.; Jochems, A.; Schouwenburg, M.; Aarts, M.; Akkooi, A. van; Berkmortel, F. van den; Eertwegh, A. van den; Groot, J. de; Hoeven, J. van der; Hospers, G.; Kapiteijn, E.; Koornstra, R.; Kmit, W.; Louwman, M.; Piersma, D.; Rijn, R. van; Suijkerbuijk, K.; Tije, A. ten; Vreugdenhil, G.; Wouters, M.; Zeijl, M. van; Haanen, J.; Uyl-de Groot, C.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-11-30
Language
English
Is part of
Value in Health (2017), Vol. 20, no. 9, p. A431-A431
